Revision as of 15:48, 13 April 2026

Nordics

Norway, Sweden, Denmark, Finland — digital health hub.

Norway 🇳🇴

Company	Category	Funding	Status
Noteless	AI Clinical Documentation	€3.5M Seed	Active, 3,000+ clinicians
Dr. Dropin	Digi-Physical Healthcare	€19.2M	Expanding to London
Nolla Health	AI Dermatology	$4.5M	Launched in US
Dignio	Remote Patient Monitoring	Acquired by Summa Equity	NHS pilot in UK
Holberg EEG	AI Neurodiagnostics	Acquired by Natus	Global autoSCORE launch
No Isolation	Social Impact Robots	Undisclosed	Deployed in UK+
Journalia	AI Healthcare Admin	$1M	Early stage

Sweden 🇸🇪

Company	Category	Funding	Status
Neko Health	Preventive Health / AI Scanning	$260M ($1.8B val)	Clinics in Stockholm, London, NYC planned
Tandem Health	AI Clinical OS	€42.6M Series A	200K+ NHS staff, 5 EU markets
Kry / Livi	Telehealth	$316M+ (~$2B val)	Profitable, 5 countries
Mindler	Digital Mental Health	$8.7M	Acquired ieso UK, Medified FI
Dentio	AI Dental	$2.3M (a16z)	Early stage
Cellcolabs	Stem Cell Manufacturing	$12M	Bryan Johnson-backed
Sakura	B2B Mental Health	Pre-seed	Female-founded
Loovi	Preventive Health	€1M	Early stage
Doctrin	Digital Primary Care	Undisclosed	New CEO, UK expansion
Min Doktor	Online Healthcare	€4.7M	Struggling to scale
BOOST Pharma	Cell Therapy	€3.1M+	RoslinCT partnership

Key Investors

See Investors for the full list. Key names: Kinnevik, Northzone, Alliance VC, Summa Equity, Novo Holdings.

Key Topics

Soft Funding — Norwegian and EU grant programs
AI Clinical Documentation — hottest subsector: Noteless, Tandem Health, Dentio
Telehealth — Kry / Livi, Dr. Dropin, Dignio
Preventive Health — Neko Health, Loovi, Cellcolabs

Ecosystem Notes

Sweden significantly ahead of Norway in digital health funding and unicorn creation. Norway more device/RPM focused; Sweden dominates AI-first health companies. a16z entering Nordics via Dentio signals US VC interest.

@@ Line 5: / Line 5: @@
 == Norway 🇳🇴 ==
-* [[Noteless]] — €3.5M, AI clinical docs, Oslo
+{|
-* [[Dr. Dropin]] — €19.2M, digi-physical healthcare, Oslo
+|-
-* [[Nolla Health]] — $4.5M, AI dermatology, now US-focused
+! Company !! Category !! Funding !! Status
-* '''Dignio''' — remote patient monitoring, acquired by Summa Equity
+|-
-* '''Holberg EEG''' — AI neurodiagnostics, acquired by Natus Medical
+| [[Noteless]] || AI Clinical Documentation || €3.5M Seed || Active, 3,000+ clinicians
-* '''No Isolation''' — social robots for isolated children
+|-
-* '''Journalia''' — $1M, AI healthcare admin
+| [[Dr. Dropin]] || Digi-Physical Healthcare || €19.2M || Expanding to London
+|-
+| [[Nolla Health]] || AI Dermatology || $4.5M || Launched in US
+|-
+| [[Dignio]] || Remote Patient Monitoring || Acquired by [[Summa Equity]] || NHS pilot in UK
+|-
+| [[Holberg EEG]] || AI Neurodiagnostics || Acquired by Natus || Global autoSCORE launch
+|-
+| [[No Isolation]] || Social Impact Robots || Undisclosed || Deployed in UK+
+|-
+| [[Journalia]] || AI Healthcare Admin || $1M || Early stage
+|}
 == Sweden 🇸🇪 ==
-* [[Neko Health]] — $260M, $1.8B valuation, AI body scanning
+{|
-* [[Tandem Health]] — €42.6M Series A, AI clinical OS
+|-
-* [[Kry / Livi]] — $2B valuation, telehealth leader
+! Company !! Category !! Funding !! Status
-* [[Mindler]] — $8.7M, digital mental health
+|-
-* [[Dentio]] — $2.3M from a16z, AI dental
+| [[Neko Health]] || Preventive Health / AI Scanning || $260M ($1.8B val) || Clinics in Stockholm, London, NYC planned
-* [[Cellcolabs]] — $12M, stem cell manufacturing
+|-
-* '''Sakura''' — pre-seed, B2B mental health
+| [[Tandem Health]] || AI Clinical OS || €42.6M Series A || 200K+ NHS staff, 5 EU markets
-* '''Loovi''' — €1M, preventive health/longevity
+|-
-* '''Doctrin''' — digital primary care
+| [[Kry / Livi]] || Telehealth || $316M+ (~$2B val) || Profitable, 5 countries
-* '''Min Doktor''' — €4.7M, struggling to scale
+|-
-* '''BOOST Pharma''' — €3.1M, cell therapy for bone disease
+| [[Mindler]] || Digital Mental Health || $8.7M || Acquired ieso UK, Medified FI
+|-
+| [[Dentio]] || AI Dental || $2.3M (a16z) || Early stage
+|-
+| [[Cellcolabs]] || Stem Cell Manufacturing || $12M || Bryan Johnson-backed
+|-
+| [[Sakura]] || B2B Mental Health || Pre-seed || Female-founded
+|-
+| [[Loovi]] || Preventive Health || €1M || Early stage
+|-
+| [[Doctrin]] || Digital Primary Care || Undisclosed || New CEO, UK expansion
+|-
+| [[Min Doktor]] || Online Healthcare || €4.7M || Struggling to scale
+|-
+| [[BOOST Pharma]] || Cell Therapy || €3.1M+ || RoslinCT partnership
+|}
 == Key Investors ==
-* [[Investors]] — full list of Nordic and European investors
+See [[Investors]] for the full list. Key names: [[Kinnevik]], [[Northzone]], [[Alliance VC]], [[Summa Equity]], [[Novo Holdings]].
 == Key Topics ==
 * [[Soft Funding]] — Norwegian and EU grant programs
-* [[AI Clinical Documentation]] — hottest subsector (Noteless, Tandem, Dentio)
+* [[AI Clinical Documentation]] — hottest subsector: [[Noteless]], [[Tandem Health]], [[Dentio]]
+* [[Telehealth]] — [[Kry / Livi]], [[Dr. Dropin]], [[Dignio]]
+* [[Preventive Health]] — [[Neko Health]], [[Loovi]], [[Cellcolabs]]
 == Ecosystem Notes ==
-Sweden significantly ahead of Norway in digital health funding and unicorn creation. Norway more device/RPM focused; Sweden dominates AI-first health companies. a16z entering Nordics via Dentio signals US VC interest.
+Sweden significantly ahead of Norway in digital health funding and unicorn creation. Norway more device/RPM focused; Sweden dominates AI-first health companies. a16z entering Nordics via [[Dentio]] signals US VC interest.
 == See Also ==
@@ Line 40: / Line 68: @@
 * [[:Category:Norway]]
 * [[:Category:Sweden]]
+* [[Publications]]
 [[Category:Region]]